Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $71.9400 (-3.89%) ($71.7600 - $75.9700) on Wed. Apr. 12, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.75% (three month average) | RSI | 63 | Latest Price | $71.9400(-3.89%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.3% a day on average for past five trading days. | Weekly Trend | LGND advances 2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) XBI(53%) IWC(49%) IWM(49%) IWN(49%) IBB(48%) | Factors Impacting LGND price | LGND will decline at least -1.375% in a week (0% probabilities). VXX(-20%) VIXM(-16%) UUP(-12%) SMH(-12%) SHY(-11%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.375% (StdDev 2.75%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $72.87(-1.28%) | 10 Day Moving Average | $72.34(-0.55%) | 20 Day Moving Average | $71.68(0.36%) | To recent high | -6.5% | To recent low | 6.8% | Market Cap | $1.156b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |